A. Christina Hennington
Also at Target Corp
About
A. Christina Hennington has been a cornerstone of Target Corporation's leadership since joining in 2003, steadily climbing the ranks through a series of high-impact roles. Beginning as a key executive team member in 2020, she assumed responsibilities that progressively increased in scope and complexity, managing a vast merchandising portfolio and steering the company through transformative growth initiatives.
Her strategic vision was pivotal in driving over $30 billion in growth during her tenure in her previous roles, where she skillfully led efforts that included the sale of Target's pharmacy business to CVS and forging a major partnership with Ulta Beauty. These milestones underscore her commitment to driving a consumer-centric business model and positioning the company at the forefront of innovation.
In her current role as Chief Strategy and Growth Officer, which began on 07-07-2024, she continues to orchestrate the company’s strategic planning and growth endeavors. Her leadership is centered on ensuring that Target's strategy remains both differentiated and future-focused, leveraging technological advancements and fostering key strategic partnerships.
While the available documents provide a comprehensive view of her professional journey at Target, they do not include personal background details or information about her education. This biography highlights her substantial contributions and dedication to Target's ongoing success.
Past Roles
| Organization | Role | Date Range |
|---|---|---|
| Target Corporation | Executive Vice President and Chief Merchandising Officer, Hardlines, Essentials, and Capabilities | January 2020 to February 2021 |
| Target Corporation | Senior Vice President, Group Merchandise Manager, Essentials, Beauty, Hardlines, and Services | January 2019 to January 2020 |
| Target Corporation | Senior Vice President, Merchandising Essentials, Beauty, and Wellness | April 2017 to January 2019 |
Fixed Compensation
| Component Name | Amount | Payment Schedule | Additional Details |
|---|---|---|---|
| Salary | $725,000 | Annual | Fixed base salary for 2023 |
| Change in Pension Value & NDCC Earnings | $13,140 | Annual | Adjustment for pension value and nonqualified deferred compensation earnings |
| All Other Compensation | $125,425 | Annual | Includes Company Matching Contributions ($54,101 ), Life Insurance ($5,621 ), SPP Adjustments ($24,727 ), Perquisites ($40,976 ) |
| Executive Contributions (Deferred Compensation) | $1,085,181 | Deferred | Part of the deferred compensation component |
| Registrant Contributions (Deferred Compensation) | $65,442 | Deferred | Part of the deferred compensation component |
| Aggregate Earnings (Deferred Compensation) | $120,762 | Deferred | Part of the deferred compensation component |
| Aggregate Balance (Deferred Compensation) | $3,972,651 | Deferred | Part of the deferred compensation component |
Performance Compensation
Non-Equity Incentive Plan Awards (Bonus)
| Metric | Value | Additional Details |
|---|---|---|
| Performance Metrics | Incentive Operating Income & Sales | 67% weight on financial metrics and 33% weight on team scorecard |
| Threshold Payout | $94,250 | Minimum performance level for bonus eligibility |
| Target Payout | $485,750 | Expected performance level |
| Maximum Payout | $971,500 | Cap on bonus payout |
| Evaluation Period | Preceding fiscal year | Performance measured over prior year |
| Payment Schedule | Annual (typically March) | Payments made in March following the performance period |
| Employment Condition | Must be employed on payment date | Exceptions include death, disability, or retirement eligibility |
| Grant Date | 3/8/2023 | Reference date for performance period |
Equity Incentive Plan Awards
| Award Type | Threshold | Target | Maximum | Grant Date Fair Value | Grant Date | Vesting Schedule / Conditions |
|---|---|---|---|---|---|---|
| PSUs | 0 shares | 9,755 shares | 19,510 shares | $1,590,065 | 3/8/2023 | Vest based on performance measures; dividend equivalents accrue during vesting |
| PBRSUs | 4,878 shares | 6,504 shares | 8,130 shares | $1,196,541 | 3/8/2023 | Vest based on performance measures; dividend equivalents accrue during vesting |